ARTICLE | Distillery Therapeutics
Neurology
October 31, 2018 8:23 PM UTC
Rat studies suggest M1 muscarinic receptor (CHRM1)-based chemogenetic inhibition of the prelimbic paraventricular thalamic nucleus pathway could help treat cocaine addiction. The system for chemogenet...
BCIQ Company Profiles